FOLR2 and neoplasm: Collectively, these results show that FRβ+ TAMs are able to suppress both, T cells that recognize their specific antigen through a CAR or through their TCR, and suggest that deep and selective depletion of FRβ+ TAMs may functionally enhance endogenous antitumor immunity and curb tumor progression.